Maximize Your Investment Potential: Submit Your Losses to Johnson Fistel for Fate Therapeutics Shareholder Investigation
Fate Therapeutics Shareholder Investigation: Submit Your Losses to Johnson Fistel FATE Class Action Investigation has Been Commenced on Behalf of Shareholders SAN DIEGO, Jan. 06, 2023 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP is investigating whether Fate Therapeutics, Inc. (NASDAQ: FATE) (“Fate” or the “Company), any of its executive officers, or others…